Japan Prevention Trial of Diabetes by Pitavastatin in Patients With Impaired Glucose Tolerance (J-PREDICT).
Phase of Trial: Phase IV
Latest Information Update: 12 May 2016
At a glance
- Drugs Pitavastatin (Primary)
- Indications Glucose intolerance; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms J-PREDICT
- 31 Aug 2018 Biomarkers information updated
- 09 Jun 2015 Results of a subanalysis in lean patients with impaired glucose tolerance presented at the 75th Annual Scientific Sessions of the American Diabetes Association.
- 19 Sep 2014 Post-hoc analysis results were presented at the 50th Annual Meeting of the European Association for the Study of Diabetes.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History